Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer.

Discoidin domain receptor 2 () is arising as a promising therapeutic target in breast carcinoma (BC). The ability of to bind to collagen promotes protumoral responses in cancer cells that influence the tumor microenvironment (TME). Nonetheless, the interrelation between expression and TME modulation during BC progression remains poorly known.